Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127257142 | 12725714 | 2 | F | 20160907 | 20160908 | 20160915 | EXP | PHHY2016TR123594 | SANDOZ | KAVALCI C, OZTURK D, ALTINBILEK E, CALTITI C. HEMOPHAGOCYTIC SYNDROME: A CASE REPORT. JOURNAL OF CLINICAL AND ANALYTICAL MEDICINE. 2016;7(5):737-9 | 28.00 | YR | F | Y | 0.00000 | 20160915 | OT | TR | TR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127257142 | 12725714 | 1 | PS | CICLOSPORIN | CYCLOSPORINE | 1 | Unknown | UNK | 65017 | ||||||||||
| 127257142 | 12725714 | 2 | SS | DEXAMETHASONE. | DEXAMETHASONE | 1 | Unknown | 20 MG, QD | 0 | 20 | MG | QD | |||||||
| 127257142 | 12725714 | 3 | SS | ETOPOSIDE. | ETOPOSIDE | 1 | Unknown | 150 MG/M2, QD | 0 | 150 | MG/M**2 | QD | |||||||
| 127257142 | 12725714 | 4 | SS | MEROPENEM. | MEROPENEM | 1 | Unknown | 1500 MG, QD | 0 | 1500 | MG | QD | |||||||
| 127257142 | 12725714 | 5 | SS | ANIDULAFUNGIN | ANIDULAFUNGIN | 1 | Unknown | 100 MG, QD | 0 | 100 | MG | QD | |||||||
| 127257142 | 12725714 | 6 | C | CRYOPRECIPITATE | CRYOPRECIPITATED ANTIHEMOPHILIC FACTOR (HUMAN) | 1 | Unknown | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127257142 | 12725714 | 1 | Histiocytosis haematophagic |
| 127257142 | 12725714 | 2 | Histiocytosis haematophagic |
| 127257142 | 12725714 | 3 | Histiocytosis haematophagic |
| 127257142 | 12725714 | 4 | Histiocytosis haematophagic |
| 127257142 | 12725714 | 5 | Histiocytosis haematophagic |
| 127257142 | 12725714 | 6 | Blood fibrinogen decreased |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127257142 | 12725714 | HO |
| 127257142 | 12725714 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127257142 | 12725714 | Disseminated intravascular coagulation | |
| 127257142 | 12725714 | General physical health deterioration | |
| 127257142 | 12725714 | Product use issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |